Research
Starting with a statin or statin plus ezetimibe to lower LDL led to similar heart outcomes
The Brief
- Adults with heart or blood vessel disease who started with a statin alone had heart attack, stroke and other heart problem rates over three years similar to those starting with statin plus ezetimibe.
- The finding comes from a study reported by Medical Xpress on 2026-11-09.
- Ezetimibe is a nonstatin medication that limits cholesterol absorption.
Why it matters
For patients with established heart or blood vessel disease, starting with a statin alone may give similar three-year cardiovascular outcomes to starting with a statin plus ezetimibe, which is relevant to LDL-lowering treatment decisions.
Who’s affected
- clinicians treating patients with cardiovascular disease
- patients with heart or blood vessel disease
- researchers in cardiology and lipid medicine
- #statins
- #ezetimibe
- #cholesterol
- #cardiovascular disease
- #ldl
- #heart attack
Adults with heart or blood vessel disease who started treatment with a statin alone had rates of heart attack, stroke and other heart problems over three years similar to those who started with a statin plus ezetimibe (a nonstatin medication to help limit cholesterol absorption…
Timeline
Medical Xpress reports that statin alone and statin plus ezetimibe led to similar heart outcomes over three years
Medical Xpress - latest medical and health news stories
Starting with a statin or statin plus ezetimibe to lower LDL led to similar heart outcomes